These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2005-001623-11 Docetaxellel bövített standard 5-fluorouracil plusz ciszplatin alapú neoadjuváns kemoterápia plusz ciszplatin alapú radiokemoterápia összehasonlítása a standard ciszplatin alapú radiokemoterápiával l... not-yet-due
Ongoing 2006-001694-23 Efficacy of cetuximab in locally advanced or metastatic adenoid cystic carcinoma. Phase II. not-yet-due
Ongoing 2006-004981-14 Phase II., non randomized, open study: inoperable gall bladder or biliary tract EGFR expressing carcinoma treatment with Erbitux and 5-fluorouracil, epiadriamycin, mitomycin containing combination not-yet-due
Ongoing 2007-002782-12 Open, uncontrolled, non-commercial Clinical Trial of induction chemotherapy with Cetuximab, Docetaxel, Cisplatin, 5FU followed by Cetuximab + radiotherapy in the responders in locally advanced ... not-yet-due
Ongoing 2014-002014-22 An open label, single center, non-randomised, phase II study of efficacy Olaparib in patients with BRCA mutation posistive previously treated advanced ocarium cancer Olaparib hatékonyságának vizsgá... not-yet-due
Ongoing 2022-002700-21 An open label, Phase IV study to assess immunological changes in patients with glioblastoma multiforme treated with bevacizumab infusion Open label, Fázis IV vizsgálat bevacizumab infúzióval kezelt... not-yet-due